US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.990
  • -0.040-1.32%
Close Dec 27 16:00 ET
  • 2.931
  • -0.059-1.98%
Post 19:02 ET
883.15MMarket Cap-4.90P/E (TTM)

AbCellera Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
-93.49%6.6M
-78.10%10.06M
-96.15%12.19M
29.38%485.42M
-84.54%21.55M
Operating revenue
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
-93.49%6.6M
-78.10%10.06M
-96.15%12.19M
29.38%485.42M
-84.54%21.55M
Cost of revenue
0
45.96%66.44M
-92.90%1.55M
Gross profit
-90.92%38.03M
27.09%418.99M
-82.98%19.99M
Operating expense
64.81%96.68M
71.39%97.47M
-16.45%61.57M
36.03%261.08M
28.10%71.86M
26.25%58.66M
19.55%56.87M
76.30%73.69M
78.06%191.92M
83.48%56.09M
Selling and administrative expenses
24.92%22.28M
20.48%23.33M
9.58%20.72M
12.62%75.18M
21.44%19.07M
5.66%17.84M
10.44%19.36M
13.63%18.91M
36.90%66.76M
6.72%15.71M
-Selling and marketing expense
-9.60%3.14M
-18.35%3.14M
-10.77%3.37M
25.82%14.18M
15.20%3.1M
12.27%3.47M
23.11%3.84M
59.11%3.77M
63.03%11.27M
47.29%2.69M
-General and administrative expense
33.25%19.15M
30.09%20.19M
14.66%17.35M
9.94%61M
22.74%15.97M
4.18%14.37M
7.69%15.52M
6.07%15.13M
32.59%55.49M
0.97%13.02M
Research and development costs
8.05%40.97M
12.21%40.93M
-25.38%39.29M
62.83%175.66M
72.14%48.62M
42.64%37.92M
36.68%36.47M
99.68%52.65M
73.82%107.88M
64.13%28.25M
Depreciation amortization depletion
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
11.36%5.74M
14.82%5.61M
38.20%5.51M
92.67%27.84M
249.12%13.82M
-Depreciation and amortization
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
11.36%5.74M
14.82%5.61M
38.20%5.51M
92.67%27.84M
249.12%13.82M
Other operating expenses
-23.44%-3.49M
27.67%-3.31M
2.93%-3.28M
-34.12%-14.16M
-101.55%-3.38M
-31.53%-2.83M
-198.11%-4.58M
35.04%-3.37M
39.64%-10.55M
68.47%-1.68M
Operating profit
-73.20%-90.17M
-92.56%-90.14M
16.07%-51.62M
-198.23%-223.05M
-73.61%-62.68M
-230.53%-52.06M
-582.31%-46.81M
-126.72%-61.5M
2.33%227.07M
-141.56%-36.1M
Net non-operating interest income expense
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
93.30%10.74M
662.31%10.78M
1,367.52%9.76M
382.85%16.08M
8.47M
Non-operating interest income
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
93.30%10.74M
662.31%10.78M
1,367.52%9.76M
382.85%16.08M
--8.47M
Other net income (expense)
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
78.53%2.05M
-36.90%-1.97M
3.59M
33.47%-4.05M
31.10%-3.78M
Other non- operating income (expenses)
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
78.53%2.05M
-36.90%-1.97M
--3.59M
33.47%-4.05M
31.10%-3.78M
Income before tax
-59.47%-62.63M
-26.79%-48.19M
11.22%-42.75M
-172.79%-174.03M
-54.72%-48.6M
-184.31%-39.28M
-451.90%-38M
-120.86%-48.15M
9.10%239.1M
-137.08%-31.41M
Income tax
-8.05%-11.53M
-50.58%-11.26M
73.41%-2.14M
-134.29%-27.63M
4.41%-1.45M
-153.43%-10.67M
-7,301.98%-7.48M
-112.92%-8.04M
22.68%80.58M
-106.13%-1.52M
Net income
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
Net income continuous Operations
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
Minority interest income
Net income attributable to the parent company
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
Basic earnings per share
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-191.07%-0.51
-70.00%-0.17
-211.11%-0.1
-450.00%-0.11
-123.73%-0.14
0.00%0.56
-145.45%-0.1
Diluted earnings per share
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-202.00%-0.51
-70.00%-0.17
-225.00%-0.1
-450.00%-0.11
-125.93%-0.14
4.17%0.5
-152.63%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M-93.49%6.6M-78.10%10.06M-96.15%12.19M29.38%485.42M-84.54%21.55M
Operating revenue -1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M-93.49%6.6M-78.10%10.06M-96.15%12.19M29.38%485.42M-84.54%21.55M
Cost of revenue 045.96%66.44M-92.90%1.55M
Gross profit -90.92%38.03M27.09%418.99M-82.98%19.99M
Operating expense 64.81%96.68M71.39%97.47M-16.45%61.57M36.03%261.08M28.10%71.86M26.25%58.66M19.55%56.87M76.30%73.69M78.06%191.92M83.48%56.09M
Selling and administrative expenses 24.92%22.28M20.48%23.33M9.58%20.72M12.62%75.18M21.44%19.07M5.66%17.84M10.44%19.36M13.63%18.91M36.90%66.76M6.72%15.71M
-Selling and marketing expense -9.60%3.14M-18.35%3.14M-10.77%3.37M25.82%14.18M15.20%3.1M12.27%3.47M23.11%3.84M59.11%3.77M63.03%11.27M47.29%2.69M
-General and administrative expense 33.25%19.15M30.09%20.19M14.66%17.35M9.94%61M22.74%15.97M4.18%14.37M7.69%15.52M6.07%15.13M32.59%55.49M0.97%13.02M
Research and development costs 8.05%40.97M12.21%40.93M-25.38%39.29M62.83%175.66M72.14%48.62M42.64%37.92M36.68%36.47M99.68%52.65M73.82%107.88M64.13%28.25M
Depreciation amortization depletion 543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M11.36%5.74M14.82%5.61M38.20%5.51M92.67%27.84M249.12%13.82M
-Depreciation and amortization 543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M11.36%5.74M14.82%5.61M38.20%5.51M92.67%27.84M249.12%13.82M
Other operating expenses -23.44%-3.49M27.67%-3.31M2.93%-3.28M-34.12%-14.16M-101.55%-3.38M-31.53%-2.83M-198.11%-4.58M35.04%-3.37M39.64%-10.55M68.47%-1.68M
Operating profit -73.20%-90.17M-92.56%-90.14M16.07%-51.62M-198.23%-223.05M-73.61%-62.68M-230.53%-52.06M-582.31%-46.81M-126.72%-61.5M2.33%227.07M-141.56%-36.1M
Net non-operating interest income expense -10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M93.30%10.74M662.31%10.78M1,367.52%9.76M382.85%16.08M8.47M
Non-operating interest income -10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M93.30%10.74M662.31%10.78M1,367.52%9.76M382.85%16.08M--8.47M
Other net income (expense) 776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M78.53%2.05M-36.90%-1.97M3.59M33.47%-4.05M31.10%-3.78M
Other non- operating income (expenses) 776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M78.53%2.05M-36.90%-1.97M--3.59M33.47%-4.05M31.10%-3.78M
Income before tax -59.47%-62.63M-26.79%-48.19M11.22%-42.75M-172.79%-174.03M-54.72%-48.6M-184.31%-39.28M-451.90%-38M-120.86%-48.15M9.10%239.1M-137.08%-31.41M
Income tax -8.05%-11.53M-50.58%-11.26M73.41%-2.14M-134.29%-27.63M4.41%-1.45M-153.43%-10.67M-7,301.98%-7.48M-112.92%-8.04M22.68%80.58M-106.13%-1.52M
Net income -78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M
Net income continuous Operations -78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M
Minority interest income
Net income attributable to the parent company -78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M
Basic earnings per share -70.00%-0.17-18.18%-0.130.00%-0.14-191.07%-0.51-70.00%-0.17-211.11%-0.1-450.00%-0.11-123.73%-0.140.00%0.56-145.45%-0.1
Diluted earnings per share -70.00%-0.17-18.18%-0.130.00%-0.14-202.00%-0.51-70.00%-0.17-225.00%-0.1-450.00%-0.11-125.93%-0.144.17%0.5-152.63%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List